BrainStorm Cell Therapeutics
BCLI
#10362
Rank
A$11.03 M
Marketcap
A$1.00
Share price
13.56%
Change (1 day)
-73.74%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Net assets

Net assets on the balance sheet as of September 2025 : -A$11.48 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has -A$11.48 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BrainStorm Cell Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-A$12.49 Million75.06%
2023-12-31$-A$7.14 Million60.94%
2022-12-31$-A$4.44 Million-116.61%
2021-12-31$A$26.67 M-42.15%
2020-12-31$A$46.12 M-364.19%
2019-12-31$-A$17.46 Million-345.19%
2018-12-31$A$7.12 M-5.46%
2017-12-31$A$7.53 M-45.17%
2016-12-31$A$13.73 M-29.17%
2015-12-31$A$19.39 M137.78%
2014-12-31$A$8.15 M165.61%
2013-12-31$A$3.07 M-19.86%
2012-12-31$A$3.83 M164.04%
2011-12-31$A$1.45 M-421.16%
2010-12-31$-A$0.46 Million-76.71%
2009-12-31$-A$1.95 Million-34.06%
2008-12-31$-A$2.95 Million5.95%
2007-12-31$-A$2.78 Million20.55%
2006-12-31$-A$2.31 Million
2006-03-31$-A$11.21 Million-1329.43%
2005-03-31$A$0.91 M-2284.87%
2004-03-31$-A$0.05 Million-223.64%
2003-03-31$A$0.03 M-65.48%
2002-03-31$A$0.09 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
A$32.01 B-279,002.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$0.78 Billion 6,673.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A$3.80 B-33,252.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.16 B-236,776.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-A$0.42 Billion 3,550.96%๐Ÿ‡บ๐Ÿ‡ธ USA